Raptor Pharmaceuticals Fails Phase 2b Liver Study In Children, Falls 37% By: TalkMarkets September 14, 2015 at 19:40 PM EDT Shares of Raptor Pharmaceuticals are down 37% after announcing failure of its phase 2b NASH study. Read More >>